NCT07543887Completed
Selpercatinib and Body Composition
Source: ClinicalTrials.gov · Last updated 22 Apr 2026
Brief summary (registry, in English)
investigation of body composition
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 15 (actual)
- First submitted
- 5 Apr 2026
- Start date
- 12 Apr 2024
- Primary completion date
- 4 Apr 2026
- Lead sponsor
- University of Pisa
- Diseases
- Thyroid cancer, Childhood cancers
- NCT number
- NCT07543887
What you commit to
- Study type: Observational
- Participants enrolled: 15
- From 12 Apr 2024 to the primary completion date, 4 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- Inability to provide informed consent
Who the study is looking for
- Adults (≥18 years old)
- Diagnosis of thyroid cancer
- Ongoing treatment with selpercatinib
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital of Pisa Coordinator of this site? Confirm its status | Pisa | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.